301 related articles for article (PubMed ID: 12950156)
1. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis.
Barisić N; Logan P; Pikija S; Skarpa D; Blau N
Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156
[TBL] [Abstract][Full Text] [Related]
2. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.
Steinfeld R; Heim P; von Gregory H; Meyer K; Ullrich K; Goebel HH; Kohlschütter A
Am J Med Genet; 2002 Nov; 112(4):347-54. PubMed ID: 12376936
[TBL] [Abstract][Full Text] [Related]
3. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
[TBL] [Abstract][Full Text] [Related]
4. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.
Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N
Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316
[TBL] [Abstract][Full Text] [Related]
5. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
[TBL] [Abstract][Full Text] [Related]
6. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
Worgall S; Kekatpure MV; Heier L; Ballon D; Dyke JP; Shungu D; Mao X; Kosofsky B; Kaplitt MG; Souweidane MM; Sondhi D; Hackett NR; Hollmann C; Crystal RG
Neurology; 2007 Aug; 69(6):521-35. PubMed ID: 17679671
[TBL] [Abstract][Full Text] [Related]
7. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].
Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES
Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559
[TBL] [Abstract][Full Text] [Related]
8. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
[TBL] [Abstract][Full Text] [Related]
9. A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children.
Tessa A; Simonati A; Tavoni A; Bertini E; Santorelli FM
Hum Mutat; 2000 Jun; 15(6):577. PubMed ID: 10862088
[TBL] [Abstract][Full Text] [Related]
10. Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations.
Lin L; Lobel P
Hum Mutat; 2001 Aug; 18(2):165. PubMed ID: 11462245
[TBL] [Abstract][Full Text] [Related]
11. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
[TBL] [Abstract][Full Text] [Related]
12. Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency.
Le NM; Parikh S
J Child Neurol; 2012 Feb; 27(2):234-7. PubMed ID: 21940688
[TBL] [Abstract][Full Text] [Related]
13. Case 27-2002: late-onset infantile neuronal ceroid lipofuscinosis.
McBride KL
N Engl J Med; 2003 May; 348(21):2159. PubMed ID: 12761381
[No Abstract] [Full Text] [Related]
14. Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses.
Chang X; Huang Y; Meng H; Jiang Y; Wu Y; Xiong H; Wang S; Qin J
Brain Dev; 2012 Oct; 34(9):739-45. PubMed ID: 22245569
[TBL] [Abstract][Full Text] [Related]
15. Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.
Liu CG; Sleat DE; Donnelly RJ; Lobel P
Genomics; 1998 Jun; 50(2):206-12. PubMed ID: 9653647
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity.
Tsiakas K; Steinfeld R; Storch S; Ezaki J; Lukacs Z; Kominami E; Kohlschütter A; Ullrich K; Braulke T
Glycobiology; 2004 Apr; 14(4):1C-5C. PubMed ID: 14736728
[TBL] [Abstract][Full Text] [Related]
17. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
[TBL] [Abstract][Full Text] [Related]
18. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
[TBL] [Abstract][Full Text] [Related]
19. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
Sondhi D; Peterson DA; Giannaris EL; Sanders CT; Mendez BS; De B; Rostkowski AB; Blanchard B; Bjugstad K; Sladek JR; Redmond DE; Leopold PL; Kaminsky SM; Hackett NR; Crystal RG
Gene Ther; 2005 Nov; 12(22):1618-32. PubMed ID: 16052206
[TBL] [Abstract][Full Text] [Related]
20. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi.
Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD
Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
